Jitopropera MD 5 Tablet (10 Tab)

Medicine Information

Jitopropera MD 5 Tablet Overview:

Jitopropera MD 5 Tablet is an antiemetic medication primarily used to prevent and control severe nausea and vomiting. It is effective in managing balance-related disorders such as vertigo (severe dizziness) and Meniere’s disease, and is frequently used to alleviate acute sickness associated with migraine attacks.

Jitopropera MD is also used for the short-term management of acute anxiety, schizophrenia, mania, and other psychotic conditions characterized by overactive thoughts or behavior.

The active ingredient in Jitopropera MD 5 Tablet is Prochlorperazine Maleate, which belongs to the phenothiazine class of antipsychotics. It works by blocking specific dopamine (D2) receptors in the brain, thereby suppressing the chemical signals that trigger nausea, vomiting, and altered mental excitement.

 

Composition:

Each uncoated mouth dissolving tablet contains- Prochlorperazine Maleate: 5 mg

 

Uses & Benefits of Jitopropera MD 5 Tablet:

Jitopropera MD 5 Tablet is prescribed for the prevention and treatment of conditions such as:

• Severe Nausea and Vomiting: Effective against acute sickness triggered by motion, post-operative recovery, or acute migraine attacks.
• Vertigo and Meniere’s Disease: Helps manage disabling dizziness, spinning sensations, loss of balance, and inner ear disorders associated with Meniere’s disease.
• Short-Term Anxiety: Utilized on a limited basis to treat non-psychotic, acute anxiety states.
• Schizophrenia and Acute Mania: Sometimes used to suppress acute psychotic symptoms and overactive behaviors in conditions like schizophrenia or psychotic disorders by reducing altered brain excitement.

 

How Does Jitopropera MD 5 Tablet Works:

Prochlorperazine Maleate is the primary active component of Jitopropera MD 5 Tablet and belongs to a class of medications known as phenothiazines.

It functions by blocking specific dopamine (D2) receptors in the brain's Chemoreceptor Trigger Zone (CTZ). The CTZ acts as a sensory control center that detects toxins or emetic signals in the bloodstream and commands the body to feel nauseous or to vomit.

By blocking dopamine at this site, the medication effectively dampens these chemical triggers, which rapidly suppresses the urge to vomit and stabilizes inner-ear signaling to control vertigo.

 

Dosage of Jitopropera MD 5 Tablet:

• Usage Direction

Take Jitopropera MD 5 Tablet exactly as advised by your doctor, following the prescribed dose and timing. Jitopropera MD 5 Tablet should be dissolved in the mouth, no need to swallow, preferably at the same time each day. Do not stop or alter the dose of Jitopropera MD 5 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. If you are unsure about the administration procedures of Jitopropera MD 5 Tablet, consult with your doctor or pharmacist.

• Missed Dose

If you miss a dose of Jitopropera MD 5 Tablet, take it as soon as you remember on the same day. But, if it is almost time for your next scheduled dose, skip the one you missed and continue following your regular dosing schedule. Avoid taking two doses if you realize you've missed one. If you often frequently forget your medication, consult your doctor to reassess your dosing plan. Missing doses regularly can lead to undesired outcomes.

You can set reminders on your smartphone, keep drug organizer boxes, or use other audio-visual technologies to prevent missing a dose.

• Overdose

If you accidentally take Jitopropera MD 5 Tablet more than your prescribed dose, seek immediate medical advice or go to the nearby poison control center. An overdose can induce serious side effects like extreme sleepiness, severe muscle tremors, agitation, rapid or irregular heartbeats, drop in blood pressure, and unconsciousness.

 

Contraindications of Jitopropera MD 5 Tablet:

Do not take Jitopropera MD 5 Tablet if you have a known allergy or hypersensitivity to prochlorperazine or other phenothiazines, or any other ingredients present in this medicine.

This medication is contraindicated in individuals with blood dyscrasias, severe liver disease, kidney impairment, pheochromocytoma, or severe cardiovascular disorders.

It must never be administered to patients in comatose states, those suffering from circulatory collapse, or individuals experiencing profound central nervous system depression due to acute intoxication from alcohol, barbiturates, or narcotics. Additionally, Jitopropera MD 5 is not recommended for pediatric patients undergoing surgical procedures.

 

Precautions & Warnings of Jitopropera MD 5 Tablet:

Before starting Jitopropera MD 5 Tablet, inform your doctor if you have heart, liver, or kidney problems, along with a history of jaundice or blood-related conditions.

Elderly patients with dementia-related psychosis treated with antipsychotic drugs like prochlorperazine are at an increased risk of cardiovascular events.

Special precautions must be taken if you have Parkinson’s disease, epilepsy, or a history of fits (seizures), as this medication can lower the seizure threshold.

Caution is advised for individuals with an enlarged prostate gland (prostatic hypertrophy), difficulty passing urine, narrow-angle glaucoma, or hypothyroidism.

Inform your doctor if you have a history of agranulocytosis (low white blood cell counts), are diabetic, or are at an increased risk of developing diabetes, as this drug can cause changes in blood glucose levels.

Jitopropera MD 5 increases sensitivity to light (photosensitivity), causing sun rashes. Avoid direct exposure to prolonged sunlight, sunlamps, or tanning booths, and wear protective clothing and sunscreen outdoors.

 

Side Effects of Jitopropera MD 5 Tablet:

Jitopropera MD 5 Tablet may cause certain side effects. Most of these are mild to moderate in intensity and typically disappear as your body adjusts to the medication. Common symptoms include drowsiness, daytime sedation, dizziness, insomnia, dry mouth, excessive thirst, blurred vision, mild stuffy nose, and constipation (which, if unmanaged, can progress to severe intestinal blockage).

Although these typical reactions are usually manageable, certain serious side effects require immediate medical attention. Discontinue the medication and seek emergency medical care if you experience orthostatic hypotension (a sudden, sharp drop in blood pressure causing fainting or severe lightheadedness upon standing up), sudden fever, an unusually severe sore throat, or unexplained bruising.

Additionally, immediate intervention is required for severe allergic reactions, such as an acute skin rash, hives, and difficulty breathing or swallowing, and swelling of the face, lips, tongue, or throat.

 

Safety Related Concerns of Jitopropera MD 5 Tablet:

• Pregnancy

Jitopropera MD 5 Tablet is not recommended during pregnancy, unless clearly necessary and prescribed by a doctor. If you are pregnant or planning to become pregnant, talk to your doctor before taking this medication to weigh the benefits against potential risks to the developing baby.

• Breastfeeding

It is best to avoid or exercise extreme caution when taking Jitopropera MD 5 Tablet while breastfeeding, as Prochlorperazine could pass into the breast milk and affect the breastfed child. Therefore, consulting with your doctor before taking Jitopropera MD 5 Tablet is crucial.

• Alcohol

It is strictly recommended to avoid drinking alcohol while taking Jitopropera MD Tablet. Alcohol intensifies the sedative effects, causing severe drowsiness and respiratory depression.

• Food Interactions

There are no significant food interactions associated with Jitopropera MD 5 Tablet. It can be taken with or without meals as suggested.

To ensure safety, patients with known food allergies or dietary restrictions should consult their healthcare professional before starting the medication.

• Drug Interactions

Jitopropera MD 5 Tablet can interact with various medications, either by compromising their effectiveness or increasing the risk of toxicity. Concomitant use with central nervous system (CNS) depressants—including opioids, barbiturates, and sleeping pills can severely intensify the medication's sedative effects, leading to profound drowsiness or respiratory depression.

Furthermore, Prochlorperazine can interact with antihypertensive agents, lithium, antiepileptic medicines, and anticholinergic drugs, necessitating close clinical monitoring.

It is essential to inform your physician if you are currently taking central nervous system stimulants like adrenaline and amphetamines, or other psychiatric medications such as neuroleptics, pimozide, atomoxetine, and antidepressants. Careful medical evaluation is also required if you are using hypoglycemic agents (blood-sugar-lowering medicines), clonidine (utilized in migraine management), medications that affect bone marrow (such as carbamazepine, certain cytotoxics, or specialized antibiotics), drugs known to prolong the QT interval, ritonavir, disopyramide, or desferrioxamine, as concurrent administration may demand precise dosage adjustments to prevent serious complications.

Always inform your healthcare provider of all current prescriptions, over-the-counter medications, and supplements to avoid potential interactions.

• Using Machinery & Driving

Jitopropera MD 5 Tablet can cause significant central nervous system effects, including drowsiness, daytime sedation, and a loss of coordination. Additionally, its anticholinergic properties can induce blurred vision and sudden dizziness. Do not drive or operate heavy machinery until you are completely sure of how this medication affects your alertness.

 

Storage of Jitopropera MD 5 Tablet:

Store protected from light & moisture, at a temperature not exceeding 30°C. Keep the medicine out of reach of children.

Avoid using it after the expiry date, printed on the packaging. Dispose of expired or unused medication properly; do not throw it away casually.

 

Additional Information:

• To enhance recovery from nausea and vomiting, consume small, frequent meals rather than large portions. Avoid heavily spiced, fried, or highly aromatic foods.
• Take small sips of clear liquids, ORS, or ginger water frequently throughout the day. This helps prevent dehydration and restores electrolytes lost due to vomiting.
• To prevent sudden dizziness or fainting caused by drops in blood pressure, always transition slowly when sitting up or standing from a lying down position.
• Do not suddenly stop your medication unless your doctor specifically tells you to.
• Do not share your medicine with someone else having the same symptoms as you.

 

Frequently Asked Questions (FAQs):

Q. What is Jitopropera MD Tablet?

A. Jitopropera MD Tablet is an antiemetic (anti-sickness) medication used to stop severe nausea and vomiting. It contains Prochlorperazine Maleate as its active ingredient, which works by blocking chemical triggers in the brain to suppress the urge to vomit and stabilize balance-related disorders.

 

Q. How does Jitopropera MD 5 Tablet work?

A. Jitopropera MD 5 Tablet contains Prochlorperazine Maleate, which belongs to a class of medicines called phenothiazines. It works by blocking dopamine receptors in the brain's vomiting control center (the Chemoreceptor Trigger Zone). By stopping these chemical distress signals from reaching the brain, the medication quickly relieves nausea, prevents vomiting, and controls dizziness or vertigo.

 

Q. Can I stop taking Jitopropera MD 5 Tablet as soon as my symptoms improve?

A. No, you should not discontinue taking this medication without first consulting your healthcare provider. Abruptly stopping the treatment, especially if it was prescribed for long-term management, can trigger adverse withdrawal symptoms such as a return of acute nausea, severe dizziness, headache, or muscle tremors. Always complete the full course and follow the exact duration recommended by your physician.

 

Q. Is Jitopropera MD 5 Tablet addictive by nature?

A. No, Jitopropera MD Tablet is not considered an addictive medication, and it does not cause psychological drug cravings or physical dependence when used as directed. However, if the medication is discontinued abruptly after prolonged or long-term use, it can cause acute withdrawal symptoms. These discontinuation effects typically manifest as recurrent nausea, vomiting, dizziness, headache, or sleep disturbances. To avoid these complications, always consult your physician, who will provide a structured plan to gradually taper off the medication.

 

Q. Does Jitopropera MD 5 make you sleepy?

A. Yes, drowsiness and daytime sedation are among the most common side effects of Jitopropera MD 5 Tablet. Because this medication depresses certain activities in the central nervous system, it can significantly impair your alertness, coordination, and reaction times.

 

 

 

References:

1. Prochlorperazine 5mg tablets. Package Leaflet: Information for the User. Last Revised: May 2014. Accessed on: 25th June 2026. Click Here

2. Prochlorperazine maleate (Brown and Burk) 3 mg buccal tablets. New Zealand Consumer Medicine Information. Last Revised: 7 October 2024. Accessed on: 25th June 2026. Click Here

3. Stemetil 5mg Tablets. Prochlorperazine Maleate. PACKAGE LEAFLET: INFORMATION FOR THE USER. Last Revised: May 2024. Accessed on: 25th June 2026. Click Here